Literature DB >> 6890162

Electro-oculographic findings in Machado-Joseph disease.

D M Dawson, P Feudo, H H Zubick, R Rosenberg, H Fowler.   

Abstract

Electro-oculographic recordings (EOG) were made on 26 patients with Machado-Joseph disease or at genetic risk for that disease. All patients with clinically apparent disease (ataxia, dysarthria, spasticity, or ophthalmoparesis) had abnormal eye movements. Defects in caloric response, sinusoidal tracking, opticokinetic nystagmus (OKN), refixation saccades, and presence of gaze paretic nystagmus were detected in that order of frequency. Fourteen subjects were clinically at risk but had normal neurologic examinations or minor equivocal signs. Nine of the fourteen had abnormal EOG, with sinusoidal tracking, calories, refixation saccades, OKN, and gaze paretic nystagmus being abnormal in that order. EOG may be useful in early case detection and may contribute to genetic counseling.

Entities:  

Mesh:

Year:  1982        PMID: 6890162     DOI: 10.1212/wnl.32.11.1272

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Characteristics of oculomotor disorders of a family with Joseph's disease.

Authors:  N Shimizu; Y Takiyama; Y Mizuno; M Mizuno; K Saito; M Yoshida
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

2.  Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  C R Gordon; V Joffe; G Vainstein; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

3.  Spinocerebellar ataxia type 3 in Israel: phenotype and genotype of a Jew Yemenite subpopulation.

Authors:  Roy Zaltzman; Reuven Sharony; Colin Klein; Carlos R Gordon
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

4.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.